首页> 外文学位 >Electrospun Fibrous Scaffold for Cardiovascular Applications
【24h】

Electrospun Fibrous Scaffold for Cardiovascular Applications

机译:心血管用电纺纤维支架

获取原文
获取原文并翻译 | 示例

摘要

Cardiovascular disease is the number one cause of death in the United States, with coronary artery disease being the most common. The potential damages of blood vessels and the heart due to thrombosis, restenosis, myocardial infarction, blood clots, etc., and the successful regeneration of cardiac tissue has posed as a significant challenge. Stents have served as a viable option for coronary artery disease. However, with the insertion of uncovered metallic stents, as well as drug-eluting stents comes side effects such as bleeding, inflammation, tumor in-growth, hyperplasia and perforation. The need for a scaffold that has superior structure and material properties for the effective function of blood vessels and the repair of such vessels is necessary. Nanofibrous scaffolds as a coating for a vascular stent shows great potential for this application. This study is aimed to develop a nanofibrous scaffold as a coating membrane for stents or a stent like scaffold that will effectively promote tissue regeneration and will be used to repair cardiovascular tissue. A composite nanofibrous membrane consisting of poly (?-caprolactone) (PCL) and poliglecaprone (PGC) was fabricated by the process of electrospinning. Solutions composed of PCL and PGC with different compositions were prepared and a nanofibrous scaffold was synthesized. The nanofiber surface morphology was analyzed by using Scanning Electron Microscopy (SEM). The mechanical properties were evaluated to determine the elasticity as well as the ultimate breaking point. A study of the in vitro degradation of the different fiber compositions were performed over a 4-week period to determine the performance and the ability of the scaffold to degrade in the body. The x-ray diffraction (XRD) was used to determine the crystallographic structure and the degree of crystallinity of the composite fiber. Experimental results of in vitro degradation, using SEM, showed that the nanofibrous membrane containing equal parts of both PCL and PGC could be a relatively fast degradable new fiber membrane to support cell viability and attachment, and therefore has potential for use in cardiovascular tissue regeneration.
机译:在美国,心血管疾病是第一大死亡原因,其中最常见的是冠状动脉疾病。由血栓形成,再狭窄,心肌梗塞,血块等引起的对血管和心脏的潜在损害以及心脏组织的成功再生构成了重大挑战。支架已成为冠状动脉疾病的可行选择。但是,插入未发现的金属支架以及药物洗脱支架会带来诸如出血,炎症,肿瘤向内生长,增生和穿孔等副作用。对于具有有效的血管功能和这种血管修复的支架,需要具有优异的结构和材料性能的支架。纳米纤维支架作为血管支架的涂层在这种应用中显示出巨大的潜力。这项研究旨在开发一种纳米纤维支架,作为支架或支架等支架的涂层膜,可有效促进组织再生并用于修复心血管组织。通过静电纺丝工艺制备了由聚(ε-己内酯)(PCL)和聚丙烯酰胺(PGC)组成的复合纳米纤维膜。制备了由PCL和PGC组成不同的溶液,并合成了纳米纤维支架。通过使用扫描电子显微镜(SEM)分析纳米纤维的表面形态。评估机械性能以确定弹性以及极限断裂点。在4周的时间内进行了不同纤维成分的体外降解研究,以确定支架的性能和在体内降解的能力。 X射线衍射(XRD)用于确定复合纤维的晶体结构和结晶度。使用SEM进行体外降解的实验结果表明,包含PCL和PGC均等的纳米纤维膜可能是一种可相对快速降解的新型纤维膜,可支持细胞的活力和附着力,因此具有用于心血管组织再生的潜力。

著录项

  • 作者

    Siler-Dearring, Jaclynn.;

  • 作者单位

    North Carolina Agricultural and Technical State University.;

  • 授予单位 North Carolina Agricultural and Technical State University.;
  • 学科 Biomedical engineering.
  • 学位 M.S.
  • 年度 2017
  • 页码 80 p.
  • 总页数 80
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号